ALDER BIOPHARMACEUTICALS INC (ALDR) has 113 open-market insider trades by 19 insiders since 2014. The most active filer is John A. Latham, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Rosen Fund Ix L.p. Sevin | — | — | 2 | $42.7M | 2015-08-31 |
| Stephen M. Dow | Dir | — | 5 | $9.8M | 2017-07-18 |
| John A. Latham | CSO | — | 25 | $9.2M | 2018-11-30 |
| Randall C. Schatzman | CEOPres | — | 24 | $9.0M | 2017-02-09 |
| Rosen Ix Affiliates Fund L.p. Sevin | — | — | 1 | $8.5M | 2015-08-12 |
| John V. Jaggers | — | — | 1 | $8.5M | 2015-08-15 |
| Jeffrey T. L. Smith | Dir | — | 24 | $6.8M | 2019-10-22 |
| A/s Novo | 10% | — | 1 | $5.5M | 2014-05-13 |
| Mark James Litton | — | — | 15 | $4.8M | 2018-06-01 |
| Deepika Pakianathan | Dir10% | — | 1 | $3.5M | 2014-05-13 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jeffrey T. L. Smith | Director | Sell | $1.2M | 2019-09-16 |
| James B. Bucher | EVP & General Counsel | Sell | $26K | 2019-04-25 |
| Erin Lavelle | COO | Sell | $20K | 2019-04-25 |
| Larry Benedict | EVP and PAO | Sell | $24K | 2019-04-25 |
| Randal Hassler | EVP & Pharmaceutical Ops. | Sell | $24K | 2019-04-25 |
| Jeffrey T. L. Smith | Director | Sell | $140K |
Companies that share insiders with ALDR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-12-03 |
| John A. Latham | Chief Scientific Officer | Sell | $336K | 2018-11-01 |
| John A. Latham | CSO | Sell | $317K | 2018-11-01 |
| Jeffrey T. L. Smith | Director | Sell | $135K | 2018-11-01 |
| Jeffrey T. L. Smith | Director | Sell | $78K | 2018-10-01 |
| John A. Latham | CSO | Sell | $772K | 2018-10-01 |
| John A. Latham | CSO | Sell | $386K | 2018-10-01 |
| John A. Latham | Chief Scientific Officer | Sell | $450K | 2018-09-04 |
| Jeffrey T. L. Smith | Director | Sell | $91K | 2018-09-04 |
| Jeffrey T. L. Smith | Director | Sell | $197K | 2018-08-01 |